Medicare Part D coverage · buprenorphine · RxCUI 1431083
buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv]
Per the CMS 2026 Part D formulary file, buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] is covered by 1,103 Medicare Part D plans (21.8% of enrollable products), averaging Tier 3, with prior authorization required on 0% of covering formularies.
- 21.8%
- Plan coverage
- 1,103
- Plans covering
- T3
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv]
Per the CMS 2026 Part D formulary file, buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] (RxNorm concept RXCUI 1431083, generic name buprenorphine) appears on 19 distinct formulary files spanning 1,103 Medicare Part D plan offerings - 21.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.
Real-world access to buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 5.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 74,893 Part D beneficiaries filled buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] in 2023, with total plan-and-beneficiary spending of $119,710,207 and an average per-beneficiary annual cost of $1,598.42. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] today.
Coverage Details
- Formularies covering
- 19
- Plans covering
- 1,103
- Coverage rate
- 21.8%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 5.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 74,893
- Total spending
- $119,710,207
- Avg per beneficiary
- $1,598.42
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | No | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | No | $0 | DE |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $13.10 | PA |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $17.60 | PA |
| Highmark Health Options Duals Select (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | No | $31.20 | DE |
| Community Blue Medicare HMO Signature (HMO) | Highmark Western and Northeastern New York Inc. | T3 | No | $0 | NY |
| Community Blue Medicare HMO Merit (HMO) | Highmark Western and Northeastern New York Inc. | T3 | No | $0 | NY |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
| Complete Blue PPO Merit (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
| Complete Blue PPO Distinct (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
| Complete Blue Plus PPO Merit (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
| Complete Blue PPO Merit (PPO) | Highmark Senior Health Company | T3 | No | $0 | PA |
Show the next 30 plans
| Community Blue Medicare HMO Signature (HMO) | Highmark Choice Company | T3 | No | $0 | PA |
| Security Blue HMO-POS ValueRx (HMO-POS) | Highmark Choice Company | T3 | No | $0 | PA |
| Community Blue Medicare HMO Signature (HMO) | Highmark Choice Company | T3 | No | $0 | PA |
| Together Blue Medicare HMO Signature (HMO) | Highmark Choice Company | T3 | No | $0 | PA |
| Community Blue Medicare HMO Distinct (HMO) | Highmark Choice Company | T3 | No | $0 | PA |
| Complete Blue HMO Distinct (HMO) | Highmark Choice Company | T3 | No | $0 | PA |
| Complete Blue PPO Distinct (PPO) | Highmark Senior Solutions Company | T3 | No | $0 | WV |
| Complete Blue PPO Signature (PPO) | Highmark Senior Solutions Company | T3 | No | $0 | WV |
| Complete Blue PPO Signature (PPO) | Highmark Senior Solutions Company | T3 | No | $0 | WV |
| Complete Blue PPO Merit (PPO) | Highmark Senior Solutions Company | T3 | No | $0 | WV |
| Complete Blue PPO Signature (PPO) | Highmark Bcbsd Inc. | T3 | No | $0 | DE |
| HealthSpring Preferred (HMO) | Bravo Health Pennsylvania, Inc. | T3 | No | $0 | AZ |
| HealthSpring Alliance (HMO) | Bravo Health Pennsylvania, Inc. | T3 | No | $0 | AZ |
| HealthSpring Preferred Savings (HMO) | Bravo Health Pennsylvania, Inc. | T3 | No | $0 | AZ |
| HealthSpring Preferred Full Savings (HMO) | Bravo Health Pennsylvania, Inc. | T3 | No | $0 | AZ |
| HealthSpring Preferred GA (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred Savings (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred Savings (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred Savings (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred Savings (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | MO |
| HealthSpring Preferred Savings (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | MO |
| HealthSpring Premier (HMO-POS) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | UT |
| HealthSpring Preferred (HMO) | Healthspring Healthcare OF Colorado, Inc. | T3 | No | $0 | NM |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] covered by Medicare Part D?
Yes, buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] is covered by 1,103 Medicare Part D plans (21.8% of all Part D formularies).
What tier is buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] on Medicare Part D plans?
buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] averages Tier 3 across Part D plans, ranging from Tier 1 to Tier 4.
Does buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] require prior authorization?
0% of Part D formularies require prior authorization for buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv]. Step therapy: 0%. Quantity limits: 5.3%.
How much does Medicare spend on buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv]?
In 2023, total Medicare Part D spending on buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] was $119,710,207, covering 74,893 beneficiaries. The average spend per beneficiary was $1,598.42.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA